Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GATA6 antisense RNA 1 (GATA6-AS1) is a long non-coding RNA located adjacent to the GATA6 gene, which encodes a cardiac transcription factor[4]. GATA6-AS1 is transcribed from the antisense strand and is regulated by a bidirectional promoter shared with GATA6, leading to co-expression in human tissues, most notably in the heart, ovary, colon, and small intestine[4]. Functionally, GATA6-AS1 is involved in key regulatory roles, including control of endothelial gene expression via interaction with the epigenetic regulator LOXL2, thereby modulating histone methylation and angiogenesis[1]. In cardiac biology, GATA6-AS1 is necessary for proper cardiomyocyte differentiation from pluripotent stem cells, acting as a positive regulator of GATA6 expression and mesodermal lineage gene pathways[3][4]. In the gut, GATA6-AS1 maintains epithelial mitochondrial function and energy metabolism; its downregulation is associated with increased disease severity and worse clinical outcomes in ulcerative colitis, Crohn's disease, and coeliac disease[5]. GATA6-AS1 does not encode a protein and is not considered a classical therapeutic target such as a receptor, enzyme, or transporter; rather, it acts as a gene regulator in physiology and disease[1][5]. There are currently no drugs directly targeting GATA6-AS1, but its expression serves as a biomarker for disease monitoring and possibly for the identification of therapeutic windows in certain gut pathologies and cardiac development studies[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GATA6 antisense RNA 1 (GATA6-AS1).